Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop-Reference-Cited by-同舟云学术

Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop

Published:2021-09 Issue:9 Volume:29 Page:946-954
ISSN:1319-0164
Container-title:Saudi Pharmaceutical Journal
language:en
Short-container-title:Saudi Pharmaceutical Journal

Author:

Al-Omar Hussain A.,Aljuffali Ibrahim A.,Solà-Morales Oriol

Funder

Gilead Sciences

Publisher

Elsevier BV

Subject

Pharmaceutical Science,Pharmacology

Reference25 articles.

1. Variation in Health Technology Assessment and Reimbursement Processes in Europe;Akehurst;Value Health,2017

2. Cost-conscious medications-prescribing behavior among physicians working in Saudi Arabia;Al-Omar;Arch Pharm Pract,2020

3. Pharmaceutical companies’ views on a health technology assessment (HTA) entity in Saudi Arabia;Al-Omar;Saudi Pharma J,2020

4. What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions;Al-Omar;Expert Rev Pharmacoeconomics Outcomes Res,2020

5. Albert, I., Ahmed, M., & Damrah, I. 2018. Kingdom of Saudi Arabia Healthcare Overview 2018. Colliers International MENA.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Budget impact analysis for three glucagon-like peptide-1 receptor agonist-based therapies for type 2 diabetes mellitus management in Saudi Arabia;Journal of Medical Economics;2024-03-11

2. Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process;Journal of Pharmacy & Pharmaceutical Sciences;2024-02-28

3. Real-world data: A systematic literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process;2023-10-19

4. Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review;Integrated Pharmacy Research and Practice;2023-07

5. Budget impact analysis of a bioprosthetic valve with a novel tissue versus mechanical aortic valve replacement in patients older than 65 years with aortic stenosis in Saudi Arabia;Journal of Medical Economics;2022-10-20